Estados financieros detallados de CytomX Therapeutics, Inc. (CTMX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
CytomX Therapeutics, Inc. registró ingresos de $76.2M en el último ejercicio fiscal, con un CAGR de 5 años del 2.2%.
Márgenes de los últimos 12 meses: margen bruto 98.6%, margen operativo -476.2%, margen neto -435.2%.
Al precio actual de $2.77, CTMX presenta beneficios negativos (P/E no significativo) y un ROE del -38.46%. La capitalización bursátil es de $602M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $15.0M | $71.6M | $59.5M | $57.5M | $68.4M | $37.3M | $53.2M | $101.2M | $138.1M | $76.2M |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | $15.0M | $71.6M | $59.5M | $57.5M | $68.4M | $37.3M | $53.2M | $101.2M | $138.1M | $76.2M |
| I+D | $54.8M | $92.3M | $103.9M | $131.6M | $112.9M | $114.2M | $111.6M | $77.7M | $83.4M | $68.7M |
| Generales y Administrativos | $19.9M | $25.6M | $33.5M | $36.8M | $36.0M | $39.2M | $42.8M | $30.0M | $29.7M | $29.8M |
| Gastos Operativos | $74.6M | $117.9M | $137.4M | $168.4M | $149.0M | $153.4M | $154.5M | $107.7M | $113.1M | $98.6M |
| Beneficio Operativo | -$59.6M | -$46.3M | -$77.9M | -$110.9M | -$80.5M | -$116.0M | -$101.3M | -$6.5M | $25.0M | -$22.4M |
| EBITDA | -$57.9M | -$42.0M | -$76.0M | -$100.1M | -$78.0M | -$113.2M | -$96.9M | $5.5M | $33.9M | -$15.8M |
| Gastos por Intereses | $1.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$58.9M | -$43.6M | -$70.3M | -$102.7M | -$50.9M | -$115.9M | -$99.3M | $3.3M | $32.1M | -$17.1M |
| Impuestos | -$19000 | -$513000 | $14.3M | -$427000 | $13.9M | 0 | 0 | $3.9M | $224000 | $238000 |
| Beneficio Neto | -$58.9M | -$43.1M | -$84.6M | -$102.2M | -$64.8M | -$115.9M | -$99.3M | -$569000 | $31.9M | -$17.4M |
| BPA | $-1.63 | $-1.16 | $-2.03 | $-2.26 | $-0.71 | $-1.26 | $-1.48 | $-0.01 | $0.38 | $-0.15 |
| BPA Diluido | $-1.63 | $-1.16 | $-2.03 | $-2.26 | $-0.71 | $-1.26 | $-1.48 | $-0.01 | $0.38 | $-0.15 |
| Acciones en Circulación (Diluidas) | $36.2M | $37.2M | $41.7M | $45.3M | $46.1M | $64.1M | $65.7M | $73.8M | $84.7M | $137.9M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $6.0M | $663000 | $10.3M | $1.4M |
| Beneficio Bruto | $6.0M | $663000 | $10.0M | $1.4M |
| Beneficio Operativo | -$15.8M | -$27.9M | -$19.7M | -$23.8M |
| EBITDA | -$14.0M | -$25.9M | -$17.9M | -$20.3M |
| Beneficio Neto | -$14.2M | -$26.5M | -$18.2M | -$20.7M |
| BPA | $-0.09 | $-0.17 | $-0.10 | $-0.09 |
| BPA Diluido | $-0.09 | $-0.17 | $-0.10 | $-0.09 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $104.6M | $177.5M | $247.6M | $188.4M | $191.9M | $205.5M | $193.7M | $17.2M | $38.1M | $12.7M |
| Inversiones a Corto | $77.3M | $196.6M | $188.6M | $107.7M | $124.3M | $99.7M | 0 | $157.3M | $62.6M | $124.4M |
| Cuentas por Cobrar | $2.3M | $10.1M | $97000 | $13000 | $798000 | $790000 | $36.0M | $3.4M | $3.1M | $2.0M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $188.1M | $388.6M | $445.5M | $303.3M | $324.0M | $310.3M | $237.1M | $182.9M | $107.3M | $143.9M |
| Inmovilizado Material | $4.4M | $4.2M | $6.9M | $32.8M | $29.4M | $25.3M | $21.0M | $16.2M | $10.6M | $4.7M |
| Fondo de Comercio | $949000 | $949000 | $949000 | $949000 | $949000 | $949000 | $949000 | $949000 | $949000 | $949000 |
| Activos Intangibles | $1.8M | $1.6M | $1.5M | $1.3M | $1.2M | $1.0M | $875000 | $729000 | $583000 | $438000 |
| Activos Totales | $199.1M | $397.6M | $457.1M | $341.3M | $358.7M | $339.4M | $260.9M | $201.8M | $120.5M | $151.6M |
| Cuentas por Pagar | $6.6M | $4.2M | $5.1M | $4.2M | $3.0M | $2.8M | $2.8M | $1.5M | $1.1M | $1.3M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $4.2M |
| Pasivos Corrientes | $35.8M | $61.1M | $97.9M | $85.6M | $68.1M | $77.9M | $152.6M | $155.9M | $85.8M | $46.6M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $120.6M | $327.7M | $326.2M | $290.2M | $366.4M | $339.9M | $346.6M | $249.2M | $121.0M | $52.6M |
| Reservas | -$176.4M | -$219.5M | -$315.0M | -$417.2M | -$507.7M | -$623.6M | -$722.9M | -$723.4M | -$691.6M | -$711.9M |
| Patrimonio Neto | $78.5M | $69.9M | $130.9M | $51.1M | -$7.8M | -$459000 | -$85.8M | -$47.4M | -$456000 | $99.0M |
| Deuda Total | 0 | 0 | 0 | $27.7M | $24.9M | $21.7M | $18.1M | $14.0M | $9.4M | $4.2M |
| Deuda Neta | -$181.9M | -$374.1M | -$436.1M | -$268.5M | -$291.2M | -$283.6M | -$175.6M | -$160.5M | -$91.2M | -$132.8M |
| Capital Circulante | $152.4M | $327.5M | $347.6M | $217.7M | $255.9M | $232.4M | $84.5M | $27.0M | $21.5M | $97.3M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $34.2M | $12.7M | $28.8M | $17.2M |
| Activos Totales | $158.3M | $151.6M | $359.4M | $381.2M |
| Pasivos Totales | $50.9M | $52.6M | $39.4M | $79.2M |
| Patrimonio Neto | $107.4M | $99.0M | $319.9M | $302.1M |
| Deuda Total | $5.6M | $4.2M | $2.9M | $5.7M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$58.9M | -$43.1M | -$84.6M | -$132.8M | -$32.9M | -$83.6M | -$99.3M | -$569000 | $31.9M | -$17.4M |
| Amortizaciones | $1.7M | $1.6M | $1.9M | $2.6M | $2.6M | $2.7M | $2.4M | $2.2M | $1.8M | $1.4M |
| Compensación en Acciones | $10.1M | $11.3M | $16.9M | $19.1M | $14.8M | $13.2M | $13.1M | $8.6M | $7.7M | $6.3M |
| Cambio en Capital Circulante | $43.3M | $190.0M | -$8.0M | -$31.4M | $18.1M | -$54.7M | -$30.7M | -$62.5M | -$126.4M | -$68.6M |
| Flujo de Caja Operativo | -$2.0M | $170.4M | -$75.5M | -$140.5M | $5.3M | -$119.0M | -$110.8M | -$56.0M | -$86.2M | -$75.6M |
| Inversiones (CapEx) | -$2.2M | -$1.6M | -$3.8M | -$3.5M | -$2.3M | -$1.6M | -$1.7M | -$840000 | -$310000 | -$220000 |
| Adquisiciones | $52000 | $121.3M | -$5.9M | 0 | $16.4M | -$24.1M | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$4.2M | $168.8M | -$79.3M | -$144.0M | $3.0M | -$120.6M | -$112.5M | -$56.9M | -$86.5M | -$75.8M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$15.5M | -$23.2M | -$25.5M | -$18.1M |
| Inversiones (CapEx) | $127000 | -$201000 | 0 | 0 |
| Flujo de Caja Libre | -$15.4M | -$23.4M | -$25.5M | -$18.1M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.4M | $1.5M | $4.7M | $2.6M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +376.1% | -16.9% | -3.4% | +19.0% | -45.5% | +42.5% | +90.4% | +36.4% | -44.8% |
| Crecimiento Beneficio Neto (anual) | | +26.8% | -96.3% | -20.8% | +36.6% | -78.8% | +14.3% | +99.4% | +5700.9% | -154.5% |
| Crecimiento BPA (anual) | | +28.8% | -75.0% | -11.3% | +68.6% | -77.5% | -17.5% | +99.5% | +5035.1% | -139.5% |
| Cambio en Acciones (anual) | | +2.6% | +12.1% | +8.8% | +1.8% | +39.0% | +2.5% | +12.3% | +14.8% | +62.8% |
| Crecimiento FCF (anual) | | +4111.7% | -147.0% | -81.5% | +102.0% | -4189.5% | +6.7% | +49.5% | -52.2% | +12.4% |
| Margen Bruto | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Margen Operativo | -396.1% | -64.6% | -130.9% | -192.9% | -117.7% | -311.0% | -190.6% | -6.4% | 18.1% | -29.3% |
| Margen EBITDA | -384.6% | -58.6% | -127.7% | -174.1% | -113.9% | -303.3% | -182.2% | 5.4% | 24.5% | -20.7% |
| Margen Neto | -391.5% | -60.2% | -142.2% | -177.8% | -94.7% | -310.5% | -186.8% | -0.6% | 23.1% | -22.8% |
| Margen FCF | -28.0% | 235.7% | -133.3% | -250.4% | 4.3% | -323.3% | -211.7% | -56.2% | -62.7% | -99.5% |
| Tasa Impositiva Efectiva | 0.0% | 1.2% | -20.3% | 0.4% | -27.3% | -0.0% | -0.0% | 117.1% | 0.7% | -1.4% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.12 | $4.54 | $-1.90 | $-3.18 | $0.06 | $-1.88 | $-1.71 | $-0.77 | $-1.02 | $-0.55 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $36.2M | $37.2M | $41.7M | $45.3M | $46.1M | $64.1M | $65.7M | $73.8M | $84.4M | $137.9M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -38.46% |
| Rentabilidad sobre capital invertido | -25.42% |
| Rentabilidad sobre activos | -20.89% |
| Margen bruto | 98.63% |
| Margen operativo | -476.19% |
| Margen neto | -435.21% |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 9.36 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -6.74 | -18.20 | -7.44 | -3.68 | -9.23 | -3.44 | -1.08 | -201.30 | 2.71 | -28.40 |
| P/VC | 5.07 | 11.23 | 4.81 | 7.37 | -38.88 | -605.13 | -1.23 | -2.41 | -190.73 | 5.93 |
| P/V | 26.47 | 10.95 | 10.57 | 6.55 | 4.42 | 7.44 | 1.98 | 1.13 | 0.63 | 7.71 |
| Margen Bruto | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Margen Operativo | -396.1% | -64.6% | -130.9% | -192.9% | -117.7% | -311.0% | -190.6% | -6.4% | 18.1% | -29.3% |
| Margen Neto | -391.5% | -60.2% | -142.2% | -177.8% | -94.7% | -310.5% | -186.8% | -0.6% | 23.1% | -22.8% |